All established UK NEQAS schemes are supported by advice
from an appropriate UK NEQAS Steering Committee, accountable to the
UK NEQAS Board. The Chairman is normally independent of UK NEQAS
operational interests, and membership will include appropriate
experts, participants and advisors. Chairmen and members are
appointed by the UK NEQAS Board, on the advice of appropriate
professionals, and sit in their own right and normally not as
representatives of any professional or other group, though some may
fulfil an invaluable liaison function with such groups. Steering
Committees do not consider the performance of individual
participating laboratories, except in advising on performance
criteria or where this may indicate a failure in the operation of
the Scheme (and even in such cases the laboratories will not be
- To advise the Scheme Organiser(s) on the overall design and
operation of the Scheme(s), including aspects such as:
- appropriateness of the investigations surveyed
- nature of the specimens distributed
- number and frequency of specimen distribution
- source of target values
- data analysis and performance assessment
- data presentation
- communication with participants, including meetings,
newsletters, educational activities
- communication with the diagnostics industry
- research and development for the Scheme(s)
- in consultation with the Scheme Organiser, to liaise with the
relevant National Quality Assurance Advisory Panel in setting
- to promote harmonisation, in scheme design and practice, with
other UK NEQAS Schemes as appropriate.
- to consider, and advise the Scheme Organiser(s) on, the need
for initiation or termination of EQA services for investigations in
the area covered.
- to review Schemes' annual reports.
- to receive any representations, to Chairman, members or
Organiser, from participants concerning the Schemes.
- to advise the UK NEQAS Board, and where appropriate other
relevant organisations (e.g. Department of Health, Joint Working
Group on Quality Assurance, CPA(UK)Ltd, Medical Devices Agency,
Royal College of Pathologists), on any aspect of EQA or quality
assurance in the area covered
There is a Steering Committee for both the Andrology and
Embryology Schemes. They meet twice a year and approve
changes in scheme design, including the introduction of new
services and cessation of existing services. Their Chair and Deputy
Chair are elected by the Steering Committee from its membership.
Membership is as follows:
The Andrology Steering Committee (ASC)
Chair - Dr Allan Pacey
Senior Lecturer in Andrology, University of Sheffield.
Deputy Chair - Mrs Trudy Johnson
Chief Biomedical Scientist, Queen Elizabeth Hospital,
NQAAP Liaison - Mrs Beverley Duffy
Biomedical Scientist 2, Whiston Hospital, Merseyside.
Mrs Sue Kenworthy
Lead Biomedical Andrologist, Portsmouth Hospitals NHS Trust.
Mrs Janine Smith
Advanced Biomedical Scientist, Seacroft Hospital
Mrs Denise Riddell
Fertility Manager, Hampshire Hospitals NHS Foundation Trust.
Senior Biomedical Scientist, Airedale Hospital NHS FT.
The Embryology Steering Committee (ESC)
Chair & NQAAP liaison - Dr Rachel
Consultant Embryologist, Glasgow Royal Infirmary.
Deputy Chair - Mrs Ella Mair
Advanced Clinical Embryologist, Newcastle Fertility Centre at
Dr Helen Clarke
Senior Clinical Embryologist, Assisted Conception Unit,
Clinical Embryologist, Midland Fertility Services.
Dr Bryan Woodward
Senior Embryologist, IVF Consultancy Services.
Clinical Embryologist, The Hewitt Centre, Liverpool.
Embryologist, Leicester Fertility Centre.
Senior Embryologist, Herts & Essex Fertility Centre.
Webpage updated Dec 2016.